PND15 ECONOMIC CONSEQUENCES OF GENERIC SUBSTITUTION FOR ANTIEPILEPTIC MEDICATION-THE CASE OF LAMOTRIGINE
Abstract
Authors
M Duh F Andermann PE Paradis JR Weiner R Manjunath PY Crémieux
M Duh F Andermann PE Paradis JR Weiner R Manjunath PY Crémieux
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now